Option B+: ART Safety and Durability During First and Subsequent Pregnancies
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Efavirenz/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms S4
- 10 Jun 2017 Biomarkers information updated
- 10 Jun 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 09 Apr 2015 Planned End Date changed from 1 Jun 2018 to 1 Apr 2019, as reported by ClinicalTrials.gov.